Cerenome, Inc. (CNSY) stock
CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.71+0.08 (+12.14%)
Close on Nov 18, 2026Market cap $5.36MP/E –Yield –
Cerenome operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Cerenome's operating cash flow for the twelve months ending Jun 30, 2026 was -$22.18M. For fiscal 2025 it was -$20.78M. The highest annual figure on record is -$5.91M in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$20.78M | – |
| FY2024 | Dec 31, 2024 | -$10.55M | – |
| FY2023 | Dec 31, 2023 | -$12.85M | – |
| FY2022 | Dec 31, 2022 | -$12.97M | – |
| FY2021 | Dec 31, 2021 | -$10.28M | – |
| FY2020 | Dec 31, 2020 | -$8.43M | – |
| FY2019 | Dec 31, 2019 | -$5.91M | – |
| FY2018 | Dec 31, 2018 | -$11.98M | – |
| FY2017 | Dec 31, 2017 | -$18.13M | – |
| FY2016 | Dec 31, 2016 | -$19.53M | – |
| FY2015 | Dec 31, 2015 | -$20.47M | – |
| FY2014 | Dec 31, 2014 | -$30.33M | – |
| FY2013 | Dec 31, 2013 | -$34.56M | – |
| FY2012 | Dec 31, 2012 | -$32.19M | – |
| FY2011 | Dec 31, 2011 | -$35.32M | – |
| FY2010 | Dec 31, 2010 | -$23.57M | – |
| FY2009 | Dec 31, 2009 | -$23.81M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.13M | – |
| Q1 FY2026 | Mar 31, 2026 | -$6.24M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.26M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.55M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.80M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.17M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.21M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.68M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.15M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.51M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.88M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.40M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.78M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.79M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.23M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.22M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.64M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.88M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.62M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.25M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.40M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.01M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.22M | -411.2% |
| Q3 FY2020 | Sep 30, 2020 | -$2.30M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.41M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.50M | – |
| Q4 FY2019 | Dec 31, 2019 | $1.04M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.52M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.15M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.27M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.49M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.12M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.22M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.05M | – |
| Q2 FY2017 | Jun 30, 2017 | -$5.03M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.83M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.16M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.64M | – |
| Q2 FY2016 | Jun 30, 2016 | -$5.68M | – |
See a number that looks wrong?